Stop the Stigma: Buy More Psych Drugs?

Little known but Extremely Relevant Fact: The Campaign to “Stop the Stigma” of “Mental Illness” was launched by the Pharmaceutical Industry.

Lately we have been reading a deluge of news articles from all around the country about various campaigns to “stop the stigma of mental illness.” We wondered what all the fuss was about.

With a seemingly altruistic agenda, the fact is the campaign to end the “stigma” of mental illness is one driven and funded by those who benefit from more and more people being labeled mentally ill — pharma, psychiatry and pharmaceutical front groups such as NAMI and CHADD.

For example, take NAMI’s campaign to stop the “stigma” and “end discrimination” against the mentally ill — the “Founding Sponsors” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs. So next time you see an ad promoting “stop the stigma” see it for what it is, a pharmaceutical marketing campaign.

The majority of the public may or may not be familiar with these so-called mental health advocacy organizations, such as the National Alliance on Mental Illness (NAMI), Children and Adults with Attention Deficit Hyperactivity Disorder (CHADD), or the myriad of bipolar, depression or ADHD “support groups” that are inundating the internet.

But they need to be.

ARE THESE SO-CALLED MENTAL HEALTH ADVOCACY GROUPS FOR PATIENT’S RIGHTS OR PHARMA’S RIGHTS? YOU DECIDE!

These are groups operating under the guise of advocates for the “mentally ill,” which in reality are heavily funded pharmaceutical front groups — lobbying and working on state and federal laws which effect the entire nation — from our elderly in nursing homes to our military, pregnant women, nursing mothers and school children.

Presenting themselves as patient advocacy groups is highly disingenuous not only to their membership, many of which may have a sincere desire to help a loved one or a family member with mental problems, but to legislators, the press and the American public — for they have consistently lobbied for legislation that benefits the mental health and pharmaceutical industries which fund them, and not patients they claim to represent.

Certainly any organization claiming to be for the rights of patients diagnosed mentally ill would have as their primary goal, full informed consent in the field of mental health — including full and complete disclosure of all drug risks, the right to refuse treatment, the right to know that psychiatric diagnoses are not medical conditions (evident by the fact there is not one confirmatory medical or scientific test). Above all such groups would provide patients with an abundance of information on non-harmful, non- drug, medical solutions and options considering the dangerous and well documented risks of psychiatric drugs by international drug regulatory agencies.

These groups do not.

To put it simply, these groups are not what they appear to be. Yet their influence over legislation, lobbying, drug regulation (or lack thereof), and public relations campaigns is substantial and effects the entire nation. For they claim to be the voice of the “mentally ill.” But are they? Or are they the result of a brilliant marketing/lobbying campaign designed to benefit the Psycho/Pharmaceutical industry that funds them?

Go here to read how all this started!

There are groups that are not funded by pharmaceutical companies, that truly do have the best interests of the consumer/patient and parent as their goal. You can find out more about such organizations here.

Do Something About It

Show a CCHR documentary DVD to all your family, friends, neighbors, and associates.

This entry was posted in Big Muddy River Newsletter, Press Releases and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply